Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 34,099,000 | 33,754,000 | 30,821,000 | 30,186,000 | 27,889,000 |
| Cost of Goods | 11,704,000 | 11,863,000 | 10,241,000 | 10,342,000 | 9,290,000 |
| Gross Profit | 22,395,000 | 21,891,000 | 20,580,000 | 19,844,000 | 18,599,000 |
| Operating Expenses | 16,171,000 | 15,599,000 | 13,516,000 | 13,783,000 | 12,573,000 |
| Operating Income | 6,224,000 | 6,292,000 | 7,064,000 | 6,061,000 | 6,026,000 |
| Interest Expense | 856,000 | 885,000 | 771,000 | 736,000 | 717,000 |
| Other Income | 1,600,000 | 814,000 | -1,493,000 | -1,800,000 | -3,370,000 |
| Pre-tax Income | 6,968,000 | 6,221,000 | 4,800,000 | 3,525,000 | 1,939,000 |
| Income Tax | 580,000 | 953,000 | 754,000 | 1,356,000 | 877,000 |
| Net Income Continuous | 6,388,000 | 5,268,000 | 4,046,000 | 2,169,000 | 1,062,000 |
| Minority Interests | -639,000 | -623,000 | -423,000 | -637,000 | -150,000 |
| Net Income | $5,749,000 | $4,645,000 | $3,623,000 | $1,532,000 | $912,000 |
| EPS Basic Total Ops | 1.44 | 1.17 | 0.92 | 0.39 | 0.24 |
| EPS Basic Continuous Ops | 1.44 | 1.17 | 0.92 | 0.39 | 0.24 |
| EPS Diluted Total Ops | 1.43 | 1.16 | 0.91 | 0.39 | 0.23 |
| EPS Diluted Continuous Ops | 1.43 | 1.16 | 0.91 | 0.39 | 0.23 |
| EBITDA(a) | $10,175,000 | $9,440,000 | $7,427,000 | $6,183,000 | $4,430,000 |